Takeovers Panel Declares Unacceptable Circumstances for Identitii Limited’s Rights IssuePosted onFebruary 10, 2026
INOVIQ advances exosome platform in ovarian cancer diagnostics and cancer therapyPosted onDecember 5, 2025